COEP
Price
$7.78
Change
-$0.25 (-3.11%)
Updated
Jun 27 closing price
Capitalization
27.34M
QRON
Price
$0.05
Change
-$0.02 (-28.57%)
Updated
Jun 25 closing price
Capitalization
895.75K
Interact to see
Advertisement

COEP vs QRON

Header iconCOEP vs QRON Comparison
Open Charts COEP vs QRONBanner chart's image
Coeptis Therapeutics Holdings
Price$7.78
Change-$0.25 (-3.11%)
Volume$17.97K
Capitalization27.34M
Qrons
Price$0.05
Change-$0.02 (-28.57%)
Volume$14.58K
Capitalization895.75K
COEP vs QRON Comparison Chart in %
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COEP vs. QRON commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a Hold and QRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (COEP: $7.78 vs. QRON: $0.05)
Brand notoriety: COEP and QRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 29% vs. QRON: 108%
Market capitalization -- COEP: $27.34M vs. QRON: $895.75K
COEP [@Biotechnology] is valued at $27.34M. QRON’s [@Biotechnology] market capitalization is $895.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whileQRON’s FA Score has 1 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • QRON’s FA Score: 1 green, 4 red.
According to our system of comparison, both COEP and QRON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 3 TA indicator(s) are bullish while QRON’s TA Score has 3 bullish TA indicator(s).

  • COEP’s TA Score: 3 bullish, 6 bearish.
  • QRON’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, QRON is a better buy in the short-term than COEP.

Price Growth

COEP (@Biotechnology) experienced а +2.91% price change this week, while QRON (@Biotechnology) price change was -26.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COEP($27.3M) has a higher market cap than QRON($896K). COEP YTD gains are higher at: 41.455 vs. QRON (-72.676). QRON has higher annual earnings (EBITDA): -343.38K vs. COEP (-9.95M). COEP has more cash in the bank: 4.27M vs. QRON (2.14K). QRON has less debt than COEP: QRON (382K) vs COEP (2.04M). COEP has higher revenues than QRON: COEP (62.9K) vs QRON (0).
COEPQRONCOEP / QRON
Capitalization27.3M896K3,047%
EBITDA-9.95M-343.38K2,896%
Gain YTD41.455-72.676-57%
P/E RatioN/AN/A-
Revenue62.9K0-
Total Cash4.27M2.14K199,626%
Total Debt2.04M382K534%
FUNDAMENTALS RATINGS
COEP vs QRON: Fundamental Ratings
COEP
QRON
OUTLOOK RATING
1..100
6050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4498
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QRON's Valuation (4) in the null industry is significantly better than the same rating for COEP (72). This means that QRON’s stock grew significantly faster than COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (95) in the null industry is in the same range as QRON (100). This means that COEP’s stock grew similarly to QRON’s over the last 12 months.

COEP's SMR Rating (99) in the null industry is in the same range as QRON (100). This means that COEP’s stock grew similarly to QRON’s over the last 12 months.

COEP's Price Growth Rating (44) in the null industry is somewhat better than the same rating for QRON (98). This means that COEP’s stock grew somewhat faster than QRON’s over the last 12 months.

COEP's P/E Growth Rating (100) in the null industry is in the same range as QRON (100). This means that COEP’s stock grew similarly to QRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPQRON
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
52%
Momentum
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
53%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWR381.261.79
+0.47%
Quanta Services
WK65.820.02
+0.03%
Workiva
NECB23.34-0.02
-0.09%
NorthEast Community Bancorp
NVAX6.38-0.13
-1.92%
Novavax
KLTO0.72-0.53
-42.39%
Klotho Neurosciences Inc

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
-3.11%
TVRD - COEP
38%
Loosely correlated
-2.38%
QRON - COEP
36%
Loosely correlated
N/A
NRXP - COEP
27%
Poorly correlated
-2.29%
APLT - COEP
26%
Poorly correlated
-14.79%
PDSB - COEP
25%
Poorly correlated
-2.76%
More

QRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, QRON has been loosely correlated with COEP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if QRON jumps, then COEP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QRON
1D Price
Change %
QRON100%
N/A
COEP - QRON
36%
Loosely correlated
-3.11%
SPHDF - QRON
27%
Poorly correlated
N/A
RENB - QRON
25%
Poorly correlated
-16.16%
MNPR - QRON
25%
Poorly correlated
-4.03%
TVGN - QRON
24%
Poorly correlated
+5.08%
More